相关实验视频
Updated: May 24, 2025

08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.0K
炎症性肠病住院率的增加是与年龄有关的影响:加拿大人口研究
Shane W Goodwin1, Piotr Wilk2,3, Yuhong Yuan1,4
1Department of Medicine, Lawson Health Research Institute, London Health Science Centre, London, Ontario, Canada.
The American journal of gastroenterology
|March 4, 2025
概括
炎症性肠病 (IBD) 的住院风险随着年龄和出生队列的增长而增加. 年龄是主要的驱动因素,需要为日益增长的IBD患病率的老年人口分配医疗保健资源.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 胃肠病学 胃肠病学
背景情况:
- 在全球范围内,炎症性肠病 (IBD) 的患病率正在上升.
- 了解IBD的住院风险因素对于医疗保健规划至关重要.
- 加拿大医疗保健数据为研究IBD住院趋势提供了独特的机会.
研究的目的:
- 调查年龄,周期和出生队列对加拿大IBD患者全因住院风险的影响.
- 随着时间的推移,确定IBD相关住院的趋势.
- 为了为老龄化IBD人口的资源分配提供信息.
主要方法:
- 利用了加拿大社区健康调查数据 (2005-2014) 与出院摘要数据库相关联.
- 采用随机效应的2级模型来分析年龄,时期和队列对住院风险的影响.
- 包括估计有197,000名符合条件的IBD患者.
主要成果:
- 3年内住院的风险随着年龄和出生队伍的增长而增加.
- 年龄较大的出生队伍面临着更高的住院风险.
- 年龄影响是主要的驱动因素,克罗恩病和性结肠炎在各个年龄组都有不同的模式.
结论:
- 年龄是影响IBD住院风险的主要因素.
- 应优先考虑医疗保健资源,以减轻IBD患者与年龄有关的住院风险.
- 需要采取积极的措施来管理加拿大老龄化人口中IBD医疗负担的增加.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
157
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
157
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
293
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
293
Inflammatory Bowel Disease I: Ulcerative Colitis
112
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
112
Chronic Bowel Disorders: Introduction
376
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
376
Inflammatory Bowel Disease IV: Pharmacological Management
88
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
88
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130

